Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts

Oncogene

Volumn 24, Issue 12, 2005, Pages 2096-2103

  Yang, Hongying ^a   Asaad, Nesrin ^a,b   Held, Kathryn D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bystander responses; Fibroblasts; Reactive oxygen species; Transwell system; X ray

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE; REACTIVE OXYGEN METABOLITE;

ALPHA RADIATION; ARTICLE; BYSTANDER EFFECT; CELL COMMUNICATION; CLONOGENIC ASSAY; CONTROLLED STUDY; FIBROBLAST; GAMMA RADIATION; HUMAN; HUMAN CELL; LINEAR ENERGY TRANSFER; MICRONUCLEUS; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL TRANSDUCTION; X IRRADIATION; X RAY; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; REFERENCE VALUE;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

BYSTANDER EFFECT; CELL COMMUNICATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; HUMANS; REFERENCE VALUES; X-RAYS;

EID: 16444382297     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208439     Document Type: Article

References (52)

1. Azzam EI, de Toledo SM and Little JB. (2001). Proc. Natl. Acad. Sci. USA, 98, 473-478.
2. Azzam EI, de Toledo SM, Spitz DR and Little JB. (2002). Cancer Res., 62, 5436-5442.
3. Ballarini F, Biaggi M, Ottolenghi A and Sapora O. (2002). Mutat. Res., 501, 1-12.
4. Baverstock K. (2000). Mutat Res., 454, 89-109.
5. Belyakov OV, Malcolmson AM, Folkard M, Prise KM and Michael BD. (2001). Br. J. Cancer, 84, 674-679.
6. Bishayee A, Hill HZ, Stein D, Rao DV and Howell RW. (2001). Radiat. Res., 155, 335-344.
7. Clutton SM, Townsend KMS, Walker C, Ansell JD and Wright EG. (1996). Carcinogenesis, 17, 1633-1639.
8. Deshpande A, Goodwin EH, Bailey SM, Marrone BL and Lehnert BE. (1996). Radiat. Res., 145, 260-267.
9. Emerit E. (1993). Free Radic. Biol. Med., 16, 99-109.
10. Fenech M and Morley AA. (1986). Mutat. Res., 161, 193-198.
11. Fimognari C, Sauer-Nehls S, Braselmann H and Nusse M. (1997). Mutagenesis, 12, 91-95.
12. Goh KO and Sumner H. (1968). Radiat. Res., 35, 171-181.
13. Hall EJ and Hei TK. (2003). Oncogene, 22, 7034-7042.
14. Hollowell JG and Littlefield LG. (1967). JSC Med. Assoc., 63, 437-442.
15. Hollowell JG and Littlefield LG. (1968). Proc. Soc. Exp. Biol. Med., 129, 240-244.
16. Huo L, Nagasawa H and Little JB. (2001). Radiat. Res., 156, 521-525.
17. Iyer R and Lehnert BE. (2000). Cancer Res., 60, 1290-1298.
18. Karran P. (2000). Curr. Opin. Genet. Dev., 10, 144-150.
19. Khan MA, Hill RP and Van Dyk J. (1998). Int. J. Radiat. Oncol. Bio. Phys., 40, 467-476.
20. Lehnert BE, Goodwin EH and Deshpande A. (1997). Cancer Res., 51, 2164-2171.
21. Little JB. (2003). Oncogene, 22, 6978-6987.
22. Little JB, Azzam EI, de Toledo SM and Nagasawa H. (2002). Radiat. Prot. Dosimetry, 99, 159-162.
23. Little JB, Nagasawa H, Li GC and Chen DJ. (2003). Radiat. Res., 159, 262-267.
24. Lorimore SA, Coates PJ, Scobie GE, Milne G and Wright EG. (2001). Oncogene, 20, 7085-7095.
25. Lyng FM, Seymour CB and Mothersill C. (2000). Br. J. Cancer, 83, 1223-1230.
26. Lyng FM, Seymour CB and Mothersill C. (2002). Radiat. Res., 157, 365-370.
27. Matsumoto H, Hayashi S, Hatashita M, Ohnishi K, Shioura H, Ohtsubo T, Kitai R, Ohnishi T and Kano E. (2001). Radiat. Res., 155, 387-396.
28. Mothersill C and Seymour C. (1997). Int. J. Radiat. Biol., 71, 421-427.
29. Mothersill C and Seymour C. (2003). Oncogene, 22, 7028-7033.
30. Mothersill C and Seymour CB. (1998). Radiat. Res., 149, 256-262.
31. Mothersill C, Stamato TD, Perez ML, Cummins R, Mooney R and Seymour CB. (2000). Br. J. Cancer, 82, 1740-1746.
32. Nagasawa H, Huo L and Little JB. (2003). Int. J. Radiat. Biol., 79, 35-41.
33. Nagasawa H and Little JB. (1992). Cancer Res., 52, 6394-6396.
34. Narayanan PK, Goodwin EH and Lehnert BE. (1997). Cancer Res., 57, 3963-3971.
35. Narayanan PK, LaRue KEA, Goodwin EH and Lehnert BE. (1999). Radiat. Res., 152, 57-63.
36. Olive PL and Johnston PJ. (1997). Oncol. Res., 9, 287-294.
37. Parsons WB, Watkins CH, Pease GL and Childs DS. (1954). Cancer, 7, 170-189.
38. Prise KM, Folkard M and Michael BD. (2003). Oncogene, 22, 7043-7049.
39. Rogakou EP, Pilch DR, Orr AH, Ivanova VS and Bonner WM. (1998). J. Biol. Chem., 273, 5858-5868.
40. Rothkamm K and Löbrich M. (2003). Proc. Natl. Acad. Sci. USA, 100, 5057-5062.
41. Rugo RE, Secretan MB and Schieslt RH. (2002). Radiat. Res., 158, 210-219.
42. Sawant SG, Randers-Pehrson G, Geard CR, Brenner DJ and Hall EJ. (2001). Radiat. Res., 155, 397-401.
43. Seymour C and Mothersill C. (1999). Radiat. Res., 151, 505.
44. Seymour CB and Mothersill C. (1997). Radiat. Oncol. Investig., 5, 106-110.
45. Seymour CB and Mothersill C. (2000). Radiat. Res., 153, 508-511.
46. Shao C, Furusawa Y, Aoki M, Matsumoto H and Ando K. (2002). Int. J. Radiat. Biol., 78, 837-844.
47. Shao C, Stewart V, Folkard M, Michael BD and Prise KM. (2003). Cancer Res., 63, 8437-8442.
48. Souto J. (1962). Nature, 195, 1317-1318.
49. Wang B, Ohyama H, Shang Y, Fujita K, Tanaka K, Nakajima T, Aizawa S, Yukawa O and Hayata I. (2004). Radiat. Res., 161, 9-16.
50. Wu L-J, Randers-Pehrson G, Xu A, Waldren CA, Geard CR, Yu ZL and Hei TK. (1999). Proc. Natl. Acad. Sci. USA, 96, 4959-4964.
51. Zhou H, Randers-Pehrson G, Waldren CA, Vannais D, Hall EJ and Hei TK. (2000). Proc. Natl. Acad. Sci. USA, 97, 2099-2104.
52. Zhou H, Suzuki M, Geard CR and Hei TK. (2002). Mutat. Res., 499, 135-141.